Last reviewed · How we verify
Placebo of Honghuaruyi Wan — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of Honghuaruyi Wan (Placebo of Honghuaruyi Wan) — Beijing University of Chinese Medicine. This is a placebo formulation with no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of Honghuaruyi Wan TARGET | Placebo of Honghuaruyi Wan | Beijing University of Chinese Medicine | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of Honghuaruyi Wan CI watch — RSS
- Placebo of Honghuaruyi Wan CI watch — Atom
- Placebo of Honghuaruyi Wan CI watch — JSON
- Placebo of Honghuaruyi Wan alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of Honghuaruyi Wan — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-honghuaruyi-wan. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab